Surgical Treatment for Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass: a Literature Review

Obes Surg. 2021 Apr;31(4):1801-1809. doi: 10.1007/s11695-021-05251-x. Epub 2021 Feb 1.

Abstract

Roux-en-Y gastric bypass (RYGB) is an effective treatment for severe obesity and obesity-related comorbidities. Postprandial hypoglycemia may occur as a long-term complication after RYGB. This study reviews the literature on surgical treatment for intractable post-RYGB hypoglycemia to provide updated information. A search was performed in Embase and PubMed, and 25 papers were identified. Thirteen papers on reversal were included. Resolution of postprandial hypoglycemic symptoms occurred in 42/48 (88%) patients after reversal. Twelve papers on pancreatectomy were included. Resolution occurred in 27/50 (54%) patients after pancreatectomy. The optimal surgical treatment for intractable post-RYGB hypoglycemia has not been defined, but reversal of RYGB seems to be more effective than other treatments. Further research on etiology and long-term evaluation of surgical outcomes may refine treatment options.

Keywords: Literature review; Pancreatectomy; Postprandial hypoglycemia; RYGB; Reversal; Surgical treatment.

Publication types

  • Review

MeSH terms

  • Gastric Bypass* / adverse effects
  • Humans
  • Hypoglycemia* / etiology
  • Hypoglycemia* / surgery
  • Obesity, Morbid* / surgery
  • Postprandial Period
  • Reoperation